We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
As the prescription cannabinoid market heats up, FSD Pharma has tapped some expert help—in the form of a new CEO who previously headed up marketing for rival GW Pharmaceuticals.